Skip to content
★ Sign in to follow
DG

Diane G. Gerst

Board Director
Director
Total declarations
51
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (19 ops.)
€1.4M

Latest filing published 03 Jun 2026 for Amphastar Pharmaceuticals, Inc..

Filing timeline

BuySale
Diane G. Gerst

Insider track record

Disclosed buys
0
Disclosed sells
19
Signal history

Diane G. Gerst: trading record in brief

Diane G. Gerst (board member) discloses dealings in Amphastar Pharmaceuticals, Inc. to SEC (Form 4). We count 51 filings; the first trade dates from 26 March 2015 and the latest from 1 June 2026.

The open-market record consists of 19 sales worth €1.4M, with no purchase. Other entries cover 20 share grants and 12 option exercises.

The record was last updated on 3 June 2026 with a share grant in Amphastar Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Diane G. Gerst

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations51 total

25 of 51 declarations